Maybe this question has been asked and answered be

Maybe this question has been asked and answered before so excuse me for missing it if so. Barring the fact that the company can be in negotiations for acquisition or a working partnership or the such, my question has to do with studies that are out there. Can anyone ascertain where we are in studies in any category that are finished phase 3 or will be within this year? It seems we have studies all over, but none seem to be completed and it’s hard to figure out a time sequence in order to know where we are. I understand we made great announcements at ECMO and have had studies in HIV but at this point it seems there are still ongoing unfinished business that prevents us from having the ground breaking news that makes big Pharma want to clunk down the big check in acquisition or combination development. I have been holding out for many years as many of you have been speaking about. Just trying to clarify the knowns and take a little out of the roller coaster ride we are constantly on with the shorts. Once again, please excuse if this has been answered before. I try to follow as much as possible, but might’ve missed this answer.